Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for ...

TYVASO® (treprostinil) Inhalation Solution and TYVASO DPI? (treprostinil) Inhalation Powder are approved for the treatment of pulmonary hypertension associated ...







treatment of idiopathic pulmonary fibrosis
Disease-targeted pharmacotherapies of ILD are intended to slow decline in lung function, and will occasionally improve lung function [10-16].
Comprehensive care of interstitial lung disease
Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high mortality risk; expert guidance is required to aid early recognition and ...
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS ...
The aim was to determine the spread of opinions with regard to the ideal content of a new guideline and specifically on the more controversial aspects of ILD.



Autres Cours:

2017 update. Full-length version - maladies-pulmonaires-rares.fr